Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Michael J. Rider, Global General Counsel at ResMed Inc, reported the sale of multiple restricted stock units to cover tax withholding obligations from vesting events. These transactions, executed at a price of $252.38 per share, reflect common practices in managing compensation packages tied to company performance. Investors might view these transactions as a routine part of executive compensation management.
For further insights into AU:RMD stock, check out TipRanks’ Stock Analysis page.